Home > Drugs A-Z > ENEMEEZ

ENEMEEZ (Enemeez Inc. DBA Summit Pharmaceuticals)

Available Formats

Dosage Form Package Information Links
LIQUID 30 TUBE in 1 BOTTLE (17433-9876-3) > 5 mL in 1 TUBE (17433-9876-0) Label Information

Complete ENEMEEZ Information

  • Drug Facts

    Active ingredient (per mini enema)

    Docusate Sodium USP 283 mg


  • PURPOSE

    Stool Softener Laxative


  • Uses

    For relief of occasional constipation (irregularity). This product generally produces a stimulus and bowel movement in 2 to 15 minutes.


  • Warnings

    For rectal use only. This is not a suppository. Do not take orally.


  • Ask a doctor before use if you have:

    • abdominal pain, nausea or vomiting.
    • a sudden change in bowel habits that persists over a period of 2 weeks.

  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are presently taking mineral oil.


  • Stop use and ask a doctor if you:

    • have rectal bleeding.
    • failed to have a bowel movement after use. This may indicate a serious condition.
    • encounter resistance. Forcing the tube may result in injury or damage to the rectum. If product is not administered properly and occasional rectal examinations are not performed, serious complications can arise. Occasional rectal exams are imperative for patients with impaired rectal function, especially loss of sensation.
    • require a bowel program for longer than 1 week.
    • experience rectal irritation or a rash around the anus appears.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.


  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.


  • OVERDOSAGE

    In case of accidental ingestion or overdose, get medical help or contact a Poison Control Center immediately.


  • Directions

    Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children 2 years and over but not more than 12 years should consult a doctor prior to use and not exceed one unit daily (with adult supervision).

    Twist off and remove tip; Lubricate tip prior to insertion: Place a few drops of water or the product on the shaft prior to insertion. Also apply one of these lubricants to the anus before inserting the enema. With steady pressure, gently insert the tube into the rectum with care to prevent damage to the rectal wall. Squeeze to empty the contents. Continue squeezing the tube until it is removed from the rectum. Remove the disposable tube and discard. A small amount of liquid may remain in the tube after use.

    Positioning:
    For best results, lay on the left side with knees bent.

    Alternate Positions:

    • Administer while seated on the toilet.
    • Kneel with the left arm folded comfortably, then lower head and chest forward until side of face is resting on the surface.

  • Other Information

    Other Information Store at room temperature 15°-30° C (59°-86° F)


  • Inactive Ingredients

    Inactive Ingredients Polyethylene Glycol and Glycerin USP


  • QUESTIONS

    Questions or Comments: 1-888-273-9734 or www.enemeez.com


  • SPL UNCLASSIFIED SECTION

    Manufactured by:
    Enemeez, Inc., Phoenix, AZ 85050

    Distributed by:
    Alliance Labs, L.L.C
    2515 E. Rose Garden Lane, Suite #1
    Phoenix, AZ 85050


  • INGREDIENTS AND APPEARANCE
    ENEMEEZ 
    docusate sodium liquid
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:17433-9876
    Route of Administration RECTAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 283 mg  in 5 mL
    Inactive Ingredients
    Ingredient Name Strength
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:17433-9876-3 30 in 1 BOTTLE
    1 NDC:17433-9876-0 5 mL in 1 TUBE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph not final part334 06/15/2012
    Labeler - Enemeez Inc. DBA Summit Pharmaceuticals (010717819)
    Registrant - Enemeez Inc. DBA Summit Pharmaceuticals (010717819)
    Establishment
    Name Address ID/FEI Business Operations
    Enemeez Inc. DBA Summit Pharmaceuticals 010717819 manufacture(17433-9876)